What phase 3 is for, and what this page will not claim about it

Published 24 October 2026 · REVIVE LAB UAE Research Desk · 5 min read
Following the phase 2 results, retatrutide entered a phase 3 programme named TRIUMPH, comprising multiple large trials across obesity and related conditions. Phase 3 is the stage at which efficacy and safety are tested at the scale and duration regulators require; until its results are published in a citable form, this page does not report them.

What phase 3 adds

Phase 2 establishes dose-response in hundreds of participants over months. Phase 3 tests the chosen doses in thousands, over longer periods, against the endpoints regulators accept, and across the populations the compound is intended for. It is where rarer adverse events become detectable.

A compound can show striking phase 2 results and still fail phase 3, which is why the distinction is not a formality.

The TRIUMPH programme

The programme comprises several large randomised trials in adults with obesity or overweight, including populations with specific weight-related conditions. Trial registrations describe the designs; the sponsor has released topline announcements as individual trials complete.

A topline press release is not a peer-reviewed publication, and this site cites publications. As the TRIUMPH papers appear, they will be reported here with the same specificity as the phase 2 work.

The status that follows

Until phase 3 is complete and a regulator has reviewed it, retatrutide is investigational. It is not approved for any indication in any jurisdiction, and material described as retatrutide is a research compound regardless of what a seller's page implies.

That is the accurate description of the compound's status, and it is the one this catalogue uses.

Supply

Retatrutide is supplied by REVIVE LAB UAE as an investigational research material for laboratory use only, with identity by mass spectrometry and purity by HPLC for the batch. It is not approved for any use anywhere, and no dosing, administration or protocol guidance is provided.

What it costs

FormatStrengthPriceAvailability
Retatrutide Pack20 mgAED 1010In stock

Delivery is AED 40 flat and free on orders over AED 700. Payment is cash on delivery anywhere in the UAE, or USDT (TRC20) in advance, which takes 5% off the order total.

Frequently asked

What phase 3 adds?

Phase 2 establishes dose-response in hundreds of participants over months. Phase 3 tests the chosen doses in thousands, over longer periods, against the endpoints regulators accept, and across the populations the compound is intended for. It is where rarer adverse events become detectable.

Does REVIVE LAB UAE provide dosing guidance?

No. REVIVE LAB UAE supplies research materials and provides no dosing, administration or protocol guidance of any kind. Every product is sold for laboratory research use only and is not for human or veterinary consumption.

How fast is delivery in the UAE?

Stock is held in Dubai. An order confirmed before 4 PM Dubai time is dispatched the same working day, reaching Dubai and Abu Dhabi the same day and the remaining emirates within 24 hours. Delivery is AED 40 flat and free over AED 700.

Retatrutide Pack — in stock, dispatched from Dubai
HPLC-verified, lot certificate on every carton, 24-hour delivery nationwide. Browse the catalogue → All peptides UAE

Related reading

Supplied for laboratory research use only. Not for human or veterinary consumption. REVIVE LAB UAE provides no dosing, administration or protocol guidance.